We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Medy-Tox, a South Korean biopharmaceutical company, and Q-Med have entered into an agreement to collaborate on botulinum-toxin-based biopharmaceuticals.
At least 5 million people in Egypt are infected with the hepatitis C virus (HCV), U.N. Integrated Regional Information Networks (IRIN) reports, giving the country one of the highest prevalence rates of the virus in the world.
A federal court has ruled against sanofi-aventis in its patent infringement suit against Amphastar and Teva, paving the way for the FDA to review generic versions of the anticoagulant drug Lovenox.
Italy,
Norway, Russia, the UK, Canada and the Bill & Melinda Gates Foundation have donated $1.5 billion to launch the first advance market commitment (AMC) to help speed the development of a new vaccine for pneumococcal disease, a major cause of pneumonia and meningitis that kills 1.6 million people every year.
Indian drugmakers Ranbaxy Laboratories and Zenotech Laboratories have signed a global agreement to market and develop a biosimilar product, G-CSF (filgrastim).
The media and activists in South Africa have begun questioning the safety of HIV microbicide trials, one of which was halted last week after preliminary results showed the drug candidate -- Polydex Pharmaceuticals' Ushercell -- could increase the risk of HIV infection, the U.N. Integrated Regional Information Networks (IRIN) reports.
The FTC will continue to pursue an anticompetitive case against Barr Laboratories following a federal district court ruling rejecting the generic firm's motion to dismiss the case, agency sources said.
The European Medicines Agency (EMEA) has posted on its website a guideline on influenza vaccines produced from viruses with the potential to cause a pandemic, which went into effect Feb. 1.
Singapore-based biotech firm S*BIO announced that it has signed
a two-year collaboration agreement with the country's Agency for Science, Technology and Research's (A*STAR) Institute of Molecular and Cell Biology for the discovery and development of multiple compounds for the treatment of cancer.